NEW YORK (GenomeWeb News) – GenoLogics today announced that it and Illumina have signed a worldwide co-selling agreement for the Geneus LIMS software.
Under the agreement, Illumina will market a version of the software pre-configured for its next-generation sequencers and TruSeq sample preparation kits. The pre-configured version will allow researchers to accelerate implementations, track library preparation and instrument runs, and prepare basic reports in weeks instead of months.
GenoLogics' Geneus LIMS software is specifically designed for genomics and next-gen sequencing, allowing researchers to automate workflows and trace samples and projects across multiple instruments and applications within one centralized system, the Victoria, British Columbia-based company said.
Financial and other terms of the deal were not disclosed.